K. Tricker

发表

Is shared care with annual hospital review better value for money than predominantly hospital-based care in patients with established stable rheumatoid arthritis?

D. Scott, D. Symmons, Linda Mary Davies, 2006, Annals of the rheumatic diseases.

Valuing pharmacogenetic testing services: a comparison of patients' and health care professionals' preferences.

Katherine Payne, Julie Ratcliffe, J. Ratcliffe, 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families.

D. Evans, J. Varley, M. Santibanez-Koref, 1997, Cancer research.

A detailed study of loss of heterozygosity on chromosome 17 in tumours from Li – Fraumeni patients carrying a mutation to the TP53 gene

D. Evans, J. Varley, J. Birch, 1997, Oncogene.

Chromosome instability is a predominant trait of fibroblasts from Li-Fraumeni families.

J. Varley, S. Roberts, J. Boyle, 1998, British Journal of Cancer.

Wilms' tumor in the Li-Fraumeni cancer family syndrome.

P. H. Jones, J. Birch, A. Kelsey, 1993, Cancer genetics and cytogenetics.

Prostate Cancer Interim Results from the IMPACT Study : Evidence for Prostate-specific Antigen Screening in BRCA 2 Mutation Carriers

W. Foulkes, A. Ardern-Jones, E. Page, 2019 .

Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

L. Kiemeney, L. Andrews, R. Eeles, 2019, European urology.

The relationship between social deprivation, disease outcome measures, and response to treatment in patients with stable, long-standing rheumatoid arthritis.

D. Symmons, L. Davies, D. Scott, 2005, The Journal of rheumatology.

Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription

I. Bruce, W. Newman, K. Payne, 2007, Journal of clinical pharmacy and therapeutics.

Linkage studies in a Li-Fraumeni family with increased expression of p53 protein but no germline mutation in p53.

D. Lane, M. Santibanez-Koref, M. Teare, 1994, British Journal of Cancer.

A novel TP53 splicing mutation in a Li-Fraumeni syndrome family: a patient with Wilms' tumour is not a mutation carrier.

D. Evans, J. Varley, J. Birch, 1998, British Journal of Cancer.

An extended Li-Fraumeni kindred with gastric carcinoma and a codon 175 mutation in TP53.

D. Evans, J. Varley, M. Santibanez-Koref, 1995, Journal of medical genetics.

Cancer phenotype correlates with constitutional TP53 genotype in families with the Li–Fraumeni syndrome

D. Evans, J. Varley, J. Birch, 1998, Oncogene.

Linkage studies inaLi-Fraumeni family withincreased expression ofp53 protein butno germline mutation inp53

J. Heighway, J. Birch, A. Kelsey, 1994 .

University of Southern Denmark Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

L. Kiemeney, L. Andrews, R. Eeles, 2018 .

TPMT testing in rheumatology: any better than routine monitoring?

I. Bruce, W. Newman, K. Payne, 2007, Rheumatology.

A novel deletion within exon 6 of TP53 in a family with Li-Fraumeni-like syndrome, and LOH in a benign lesion from a mutation carrier.

D. Evans, J. Varley, J. Birch, 1996, Cancer genetics and cytogenetics.

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

Neil L. Aaronson, L. Kiemeney, L. Andrews, 2018, British Journal of Cancer.

The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis.

D. Symmons, David Steven Scott, L. Davies, 2005, Health technology assessment.

Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.

A. Craft, M. Santibanez-Koref, P. H. Jones, 1994, Cancer research.

Rapid Point-of-Care Genotyping to Avoid Aminoglycoside-Induced Ototoxicity in Neonatal Intensive Care

R. Body, R. Macleod, G. Miele, 2022, JAMA pediatrics.

The detection of antibodies against Schistosoma mansoni soluble egg antigens (SEA) and CEF6 in ELISA, before and after chemotherapy

D. Koech, M. Doenhoff, R. Sturrock, 2003, Annals of Tropical Medicine and Parasitology.

An enzyme-linked immunosorbent assay using Schistosoma mansoni purified egg antigen for the diagnosis of schistosomiasis in Saudi Arabia.

M. Doenhoff, K. Tricker, A. Banaja, 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Genetic and functional studies of a germline TP53 splicing mutation in a Li–Fraumeni-like family

D. Evans, J. Varley, R. Reddel, 1998, Oncogene.

A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study.

Katherine Payne, David W Ray, Simon C Ramsden, 2011, Pharmacogenomics.

Patients' and healthcare professionals' views on pharmacogenetic testing and its future delivery in the NHS.

W. Newman, K. Payne, E. Fargher, 2007, Pharmacogenomics.

The cost-effectiveness of a pharmacogenetic test: a trial-based evaluation of TPMT genotyping for azathioprine.

Katherine Payne, W. Newman, K. Payne, 2014, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Early development of infants with neurofibromatosis type 1: a case series

P. Bolton, A. Pickles, S. Baron-Cohen, 2017, Molecular Autism.

Patients with stable long-standing rheumatoid arthritis continue to deteriorate despite intensified treatment with traditional disease modifying anti-rheumatic drugs--results of the British Rheumatoid Outcome Study Group randomized controlled clinical trial.

D. Symmons, D. Scott, A. Hassell, 2006, Rheumatology.

Hereditary renal cancer patient and public involvement group: A collaborative, consensus decision process to develop a communication tool for patient use

J. Hepworth, E. Woodward, J. Rothwell, 2023, Journal of Clinical and Translational Science.

Rare variant contribution to cholestatic liver disease in a South Asian population in the United Kingdom

P. Deloukas, Klaudia Walter, G. Breen, 2022, medRxiv.

PIK3R3 is a candidate regulator of platelet count in people of Bangladeshi ancestry

P. Deloukas, G. Breen, C. Curtis, 2023, Research and practice in thrombosis and haemostasis.

Randomised controlled trial of simvastatin treatment for autism in young children with neurofibromatosis type 1 (SANTA)

Alcino J. Silva, R. Emsley, Jonathan Green, 2018, Molecular Autism.

Prostate-specific antigen velocity in a prospective prostate cancer screening study of men with genetic predisposition

L. Kiemeney, L. Andrews, R. Eeles, 2018, British Journal of Cancer.